Falling Walls 2024. Science Breakthroughs of the Year 2024 | Pitches
ActiTrexx has been awarded the main prize in the Science Start-Ups category. The company has successfully treated its first patient with Actileucel, a pioneering cell therapy designed to prevent Graft-versus-Host Disease (GvHD) after stem cell transplantation. ActiTrexx is developing a platform of patent-protected cellular and biologic therapies that target the root causes of overshooting immune responses. This approach aims to reduce the need for immunosuppressants, offering new hope for patients.